Schedule 13G ownership disclosure

Elicio Therapeutics, Inc.

Common Stock, par value $0.01 per share · CUSIP: 28657F103

Event date: 2023-12-08

Filing-level shares
587,818
Percent of class
5.45%
  • Actyus Private Equity SGIIC, S.A.

    Shares: 587,818 · Class: 5.45%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-002866
Form type
SCHEDULE 13G
Filer
Actyus Private Equity SGIIC, S.A.
CIK
CIK 2050492
Filed
Jan 07, 2025
Reporting period
Dec 08, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub